Clinical Trial

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued...

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record levelsHOUSTON, TX, Jan. 10, 2026...

Best GLP-1 Patch with Berberine (2026): Search Term Analysis as Consumers Explore Natural Transdermal Alternatives — Vitamin Patch Club’s TrimPure Gold Referenced in Category Report

Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving interest in transdermal metabolic support...

Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency

Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal disclosures, third-party COA availability, and...

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access expands through telehealth — here...

Best Berberine Patch for Transdermal Metabolic Support: NuraPatch Cited in Industry Analysis as Consumer Interest in Botanical Weight Management Options Grows

Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic...

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical...

Flywheel reports record growth, launches products to support clinical trial and medical device markets, and closes $27.5M equity round

MINNEAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Flywheel, the leading medical imaging data management and analysis platform, today announced key milestones achieved...

Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties

Combined teams and proprietary AI-technology to multiply capabilities and services as a leading provider of real-world data for clinical researchSAN...

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets – Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

error: Content is protected !!